Original post by WSU news

From left: Josh Neumiller, John White and Cheyenne Newsome

The American Diabetes Association (ADA) recently relied heavily on Washington State University researchers for updates to two publications designed to help in the management and treatment of diabetes.

In the fifth edition of Practical Insulin: A Handbook for Prescribing Providers, the American Diabetes Association (ADA) relied on Allen I. White Distinguished Associate Professor Josh Neumiller, Pharm.D, to completely revise the popular physician pocket reference. Through his contributions, Neumiller, WSU College of Pharmacy and Pharmaceutical Sciences vice chair and associate professor of pharmacotherapy, was able to provide clinicians with fresh insights on choosing an insulin regimen for effectively managing blood glucose and addressing patient and provider resistance to use of insulin. Cheyenne Newsome, Pharm.D., WSU College of Pharmacy and Pharmaceutical Sciences assistant clinical professor, served as clinical reviewer for the updated content.

The new edition was released earlier this month in San Francisco at ADA’s 79th Scientific Sessions, where more than 15,000 people (including more than 12,000 professional attendees) from 115 countries participated. Physicians, scientists and health care professionals convene at the Scientific Sessions to unveil cutting-edge research, treatment recommendations and advances toward a cure for diabetes.

Also at the conference, Neumiller was recognized with a distinguished service award for his past role as editor-in-chief of the ADA journal, Diabetes Spectrum. The award acknowledges Neumiller’s excellence in providing reliable information to clinicians and helping them overcome common treatment challenges in the management of diabetes.

A new edition of the ADA book, Medications for the Treatment of Diabetes, was also released at this year’s Scientific Sessions. R. Keith Campbell Distinguished Professor in Diabetes Care John White, Pharm.D, College of Pharmacy and Pharmaceutical Sciences chair and professor of pharmacotherapy, served as editor and author of the edition. The book is part of ADA’s Medical Management Series for health care professionals. ADA calls the book “the most authoritative guide to diabetes therapeutics available.”

Ten additional College of Pharmacy and Pharmaceutical Sciences faculty also served as chapter authors, including pharmacists Damianne Brand-Eubanks, Christina Buchman, Megan Giruzzi, Nicholas Giruzzi, Anne Kim, Kim McKeirnan, Josh Neumiller, Cheyenne Newsome, Nicole Perea, and Megan Willson. Faculty from University of California San Francisco, University of Washington, University of Colorado and University of South Carolina also served as chapter authors.

Medications for the Treatment of Diabetes is currently available in print to purchase online and will soon be available electronically. Practical Insulin: A Handbook for Prescribing Providers, 5th Edition will soon be available for purchase online in print and electronic formats.

“Diabetes is a chronic health condition that requires collaborative management from all members of the care team, including people living with diabetes. Having the opportunity to partner with an organization such as ADA to contribute to the development of educational resources that may improve patient care and outcomes is a true honor,” Neumiller said.

“Effectively addressing diabetes will not just happen, it will be the result of collective work by scores of dedicated professionals using the best available science. Although there are no simple solutions, there are coordinated efforts that are making a significant difference in the lives of those living with diabetes. We are proud to be part of those efforts,” White said.

According to ADA, diabetes affects more than 30 million children and adults in the U.S. and contributes to the deaths of more than 230,000 Americans each year. The ADA estimates that the total cost of diagnosed diabetes in the U.S. is more than $327 billion, and people with diabetes have health care costs that are more than double the costs incurred by people who do not have the disease.

Neumiller has been on faculty with the College of Pharmacy and Pharmaceutical Sciences for 11 years. He is also a member of the WSU Geriatrics Team and currently serves as chairman of ADA’s Professional Practice Committee, which annually updates the Association’s Standards of Medical Care in Diabetes. His research interests focus on issues involving the management of chronic diseases such as diabetes and chronic kidney disease. He is additionally active in research surrounding medication safety during transitions of care. Neumiller has published research, commentaries, and clinical reviews in numerous journals and frequently speaks nationally on diabetes-related topics. Neumiller was also one of the members of the planning committee for this year’s ADA Scientific Sessions.

White has more than 30 years of experience and work in the diabetes arena. He has been a College of Pharmacy and Pharmaceutical Sciences faculty member since 1989. He has published three additional books, 29 book chapters and more than 150 manuscripts on the topic of diabetes. His manuscripts have been published in numerous journals.  He has received more than 25 diabetes-related research grants and contracts and given more than 330 lectures on the topic of diabetes.